University Compounding Pharmacy, a prominent name in personalized medicine since its establishment in 1999, has officially rebranded itself as MediVera Compounding Pharmacy™. This strategic rebranding aligns with the company’s recent growth, introduction of new product lines, and expansion across the nation.
The rebranding initiative retains the company’s ownership and its dedicated team, ensuring that healthcare providers and patients continue to receive the high-level service and exceptional care they have relied on for over two decades.
In recent years, MediVera Compounding Pharmacy has experienced substantial revenue growth. The introduction of new product offerings, nationwide expansion, and a strong market position through differentiated quality products and services, such as the Impressed Advantage program, have played pivotal roles. This growth trajectory saw the company double its revenue from 2022 to 2023, and expectations are high for continued acceleration, with projections to double revenue year-over-year once again.
CEO Bradley McCloskey, PharmD, highlighted the importance of differentiation as a critical growth driver for the company. “With the Impressed Advantage customer service program, we are making the prescription process easier, faster, and more convenient for both doctors and their patients,” McCloskey stated. He also emphasized the company's plans to launch additional product offerings and expand into more states within the next few months, positioning 2024 as a year of significant growth. MediVera Compounding Pharmacy aims to extend its footprint into 14 additional states.
The rebranding of University Compounding Pharmacy to MediVera Compounding Pharmacy™ signifies more than just a name change. It represents the company’s commitment to innovation and excellence in personalized medicine. As MediVera continues to expand its reach, healthcare providers and patients can expect a broader array of tailored solutions designed to meet their unique needs.
MediVera Compounding Pharmacy is currently licensed in and ships to 33 states, including Arizona, Connecticut, Colorado, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Virginia, Vermont, Washington, Wisconsin, and Wyoming.
For more information about MediVera Compounding Pharmacy and its services, please visit mediverarx.com.
